Epilepsy and autoimmune diseases: comorbidity in a national patient cohort

Epilepsy is one of the most common chronic brain disorders, and globally 50 million people are affected [1]. Epilepsy prevalence varies between 0.5 and 1 % [2]. Common for all epileptic conditions are recurrent unprovoked seizures. Epilepsy can have severe consequences for the patient, and treatment with antiepileptic drugs is strongly recommanded for most patients. There is a wide range of antiepileptic drugs, and they can be used in combination as their mode of action varies. One third of the patients, however, does not become seizure free [3].

0